Abstract
Introduction

T-cell large granular lymphocyte leukemia (T-LGLL), a subtype of chronic lymphocytic leukemia, is a clonal proliferation of cytotoxic T lymphocytes, characterized by the CD3+, CD57+, CD56-immunophenotype and the clonal rearrangement of the T-cell receptor genes (1). It presents clinically with a rather indolent course of disease, complicated by frequent infections secondary to neutropenia, anemia, splenomegaly and autoimmune disorders especially rheumatoid arthritis. CD20 is a transmembrane protein, which has been thought to be a B-cell specific marker. Hultin et al, however, identified a distinct subpopulation of T cells expressing CD 20 molecule in peripheral blood and bone marrow from normal individuals (2). Meanwhile more than twenty cases of T-cell malignancies expressing CD20 have been reported over the past two decades
. Although 
it i o n t o CD2 0 . ( C) A S o u t h e r n b l o t a n a l y s i s o f T CR-β ( l a n e s 1 , 2 , 3 ) a n d I g H g e n e s ( l a n e s 4 , 5 ) . L e f t -s i d e l a n e s a r e g e r m l i n e c o n t r o l s a n d r i g h t -s i d e l a n e s a r e f r o m DNA o f t h e p a t i e n t . T h e r e s t r i c t i o n e n z y me s u s e d
we r e B a mH1 ( l a n e 1 ) , E c o RV ( l a n e 2 ) , Hi n d I I I ( l a n e s 3 , 5 ) , a n d B a mH1 p l u s Hi n d I I I ( l a n e 4 ) . Re a r r a n g e d b a n d s ( a r r o w) we r e d e t e c t e d i n t h e T CR-β g e n e , b u t n o t i n I g H g e n e . Fig. 1B) . (Fig. 1C) . T a b l e 1 . Cl i n i c a l F e a t u r e s o f P a t i e n t s wi t h CD2 0 -p o s i t i v e T -c e l l Ma l i g n a n c i e s 
ceptor (sIL-2R) was moderately increased (856 IU/mL; normal range, 220-530 IU/mL
Southern blot analysis
A Southern blot analysis was performed to detect the rearrangement of the T-cell receptor (TCR) β chain and immunoglobulin (Ig) heavy chain genes using a 32 P-labeled TCR-β chain gene probe (Cβ fragment) and an Ig heavy chain gene probe (JH), respectively. Rearranged bands were detected in the TCR-β gene
Discussion
T-LGLL, a subtype of chronic lymphocytic leukemia, is a clonal proliferation of CD3+ large granular lymphocytes (i.e. cytotoxic T lymphocytes), which are usually identified by a size greater than normal lymphocytes, abundant pale cytoplasm and prominent azurophilic granules. However, these features may vary, and occasionally clonally expanded lymphocytes with characteristic immunophenotype may not have LGL morphology on peripheral blood smear. It is also recognized that some patients may not have an absolute lymphocytosis. Because of this, the diagnosis may be overlooked unless the blood smear is examined carefully (1). T-LGLL should be included in the differential diagnoses in patients with unexplained cytopenias. The present case had neither absolute lymphocytosis, massive infiltration of the leukemic cells in the bone marrow, splenomegaly, nor lymphadenopathies. These features might have misled the diagnosis to aplastic anemia or myelodysplastic syndrome. Careful examination and immunophenotyping with flow cytometry was necessary to reach the correct diagnosis. The leukemic cells of this patient presented with a characteristic immunophenotypes, CD3+, CD8+, CD57+, CD56-
T a b l e 2 . I mmu n o p h e n o t y p i c F e a t u r e s o f CD2 0 -p o s i t i v e T -c e l l Ma l i g n a n c i e s and the clonal rearrangement of TCR β which indicate a diagnosis of T-cell type LGLL. Specifically in this case, they co-expressed CD20 molecule, a pan-B cell marker. The CD20 expression was confirmed using two different monoclonal antibodies to determine whether the antigen is identical to the real CD20 molecule or to a CD20-like moiety.
Among the twenty cases of mature T-cell malignancies expressing CD20, patients ranged in age from 
